Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathologic development of oral cancer

Head and Neck

Volumn 34, Issue 3, 2012, Pages 405-411

  Chien, Ming Hsien ^a,b   Chou, Lin Shih Shen ^c,d   Chung, Tsung Te ^c,e   Lin, Chien Huang ^b   Chou, Ming Yung ^c,d   Weng, Meng Shih ^f   Yang, Shun Fa ^c,d   Chen, Mu Kuan ^c,g  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^f FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^g CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

betel nut chewing; E cadherin; genetic polymorphism; oral cancer; tobacco consumption

Indexed keywords

UVOMORULIN;

ADULT; ALLELE; ARTICLE; CANCER RISK; CARCINOGENESIS; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CADHERINS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; TAIWAN;

EID: 84856954811     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21746     Document Type: Article

References (43)

1. Yang SF, Yang WE, Chang HR, Chu SC, Hsieh YS,. Luteolin induces apoptosis in oral squamous cancer cells. J Dent Res 2008; 87: 401-406.
2. Lo WY, Tsai MH, Tsai Y, et al. Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta 2007; 376: 101-107. (Pubitemid 44880973)
3. Biolchini F, Pollastri G, Figurelli S, Chiarini L,. Carcinogen metabolism, DNA damage repair and oral head and neck squamocellular carcinoma (HNSCC). A review. Minerva Stomatol 2005; 54: 405-414.
4. Chen YJ, Chang JT, Liao CT, et al. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci 2008; 99: 1507-1514.
5. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC,. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995; 24: 450-453.
6. Nagaraj NS, Beckers S, Mensah JK, Waigel S, Vigneswaran N, Zacharias W,. Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells. Toxicol Lett 2006; 165: 182-194. (Pubitemid 44202254)
7. Vairaktaris E, Yapijakis C, Serefoglou Z, et al. The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma. Anticancer Res 2008; 28: 309-314. (Pubitemid 351362918)
8. Yen CY, Liu SY, Chen CH, et al. Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med 2008; 37: 271-277.
9. Chen MK, Chiou HL, Su SC, et al. The association between hypoxia inducible factor-1alpha gene polymorphisms and increased susceptibility to oral cancer. Oral Oncol 2009; 45: e222-e226.
10. Chen MK, Tsai HT, Chung TT, et al. Glutathione S-transferase P1 and alpha gene variants; role in susceptibility and tumor size development of oral cancer. Head Neck 2010; 32: 1079-1087.
11. Teng YH, Liu TH, Tseng HC, et al. Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer. Head Neck 2009; 31: 1282-1288.
12. Takeichi M,. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-1455. (Pubitemid 121000430)
13. Christofori G, Semb H,. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999; 24: 73-76. (Pubitemid 29346577)
14. Okegawa T, Li Y, Pong RC, Hsieh JT,. Cell adhesion proteins as tumor suppressors. J Urol 2002; 167: 1836-1843. (Pubitemid 34240766)
15. Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993; 142: 987-993. (Pubitemid 24060574)
16. Kinsella AR, Lepts GC, Hill CL, Jones M,. Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines. Clin Exp Metastasis 1994; 12: 335-342. (Pubitemid 24257072)
17. Mayer B, Johnson JP, Leitl F, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993; 53: 1690-1695. (Pubitemid 23113253)
18. Pignatelli M, Ansari TW, Gunter P, et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 1994; 174: 243-248.
19. Umbas R, Schalken JA, Aalders TW, et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992; 52: 5104-5109.
20. Kudo Y, Kitajima S, Ogawa I, et al. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin Cancer Res 2004; 10: 5455-5463. (Pubitemid 39100483)
21. Mattijssen V, Peters HM, Schalkwijk L, et al. E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer 1993; 55: 580-585. (Pubitemid 23328942)
22. Shinohara M, Hiraki A, Ikebe T, et al. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour. J Pathol 1998; 184: 369-381.
23. Takes RP, Baatenburg De Jong RJ, Alles MJ, et al. Markers for nodal metastasis in head and neck squamous cell cancer. Arch Otolaryngol Head Neck Surg 2002; 128: 512-518. (Pubitemid 34493718)
24. Li LC, Chui RM, Sasaki M, et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 2000; 60: 873-876. (Pubitemid 30129518)
25. Nakamura A, Shimazaki T, Kaneko K, et al. Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutat Res 2002; 502: 19-24. (Pubitemid 34454994)
26. Shin Y, Kim IJ, Kang HC, et al. The E-cadherin -347G→GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis 2004; 25: 895-899. (Pubitemid 38886075)
27. Fei Y, Hu J, Liu S, Liu X, Wang F, Gong J,. E-cadherin-160 C/A promoter polymorphism and risk of pancreatic carcinoma in Chinese population. Cancer Genet Cytogenet 2010; 197: 25-31.
28. Kiemeney LA, van Houwelingen KP, Bogaerts M, et al. Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer. Eur J Cancer 2006; 42: 3219-3227. (Pubitemid 44854503)
29. Pittman AM, Twiss P, Broderick P, et al. The CDH1-160C→A polymorphism is a risk factor for colorectal cancer. Int J Cancer 2009; 125: 1622-1625.
30. Zou XP, Dai WJ, Cao J,. CDH1 promoter polymorphism (-347G→GA) is a possible prognostic factor in sporadic colorectal cancer. World J Gastroenterol 2009; 15: 5340-5345.
31. Zhang XF, Wang YM, Wang R, et al. Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma [in Chinese]. Ai Zheng 2005; 24: 513-519.
32. Zhang B, Pan K, Liu Z, et al. Genetic polymorphisms of the E-cadherin promoter and risk of sporadic gastric carcinoma in Chinese populations. Cancer Epidemiol Biomark Prev 2008; 17: 2402-2408.
33. Shin Y, Kim IJ, Kang HC, et al. A functional polymorphism (-347 G→GA) in the E-cadherin gene is associated with colorectal cancer. Carcinogenesis 2004; 25: 2173-2176. (Pubitemid 39534855)
34. Anderson L, Seilhamer J,. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997; 18: 533-537. (Pubitemid 27174443)
35. Wu MS, Huang SP, Chang YT, et al. Association of the -160 C→A promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 2002; 94: 1443-1448.
36. Lai KC, Lee TC,. Genetic damage in cultured human keratinocytes stressed by long-term exposure to areca nut extracts. Mutat Res 2006; 599: 66-75.
37. Ramachandran S, Ramadas K, Hariharan R, Rejnish Kumar R, Radhakrishna Pillai M,. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol 2006; 42: 350-362.
38. Lin MH, Wang CJ, Huang HP, Chou MY, Chou FP,. The tumorigenic characteristics of lime-piper betel quid-transformed JB6 cells. Arch Toxicol 2004; 78: 167-173.
39. Tseng YH, Chang KW, Liu CJ, Lin CY, Yang SC, Lin SC,. Areca nut extract represses migration and differentiation while activating matrix metalloproteinase-9 of normal gingival epithelial cells. J Periodontal Res 2008; 43: 490-499.
40. Dasgupta P, Rizwani W, Pillai S, et al. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer 2009; 124: 36-45.
41. Wei PL, Chang YJ, Ho YS, et al. Tobacco-specific carcinogen enhances colon cancer cell migration through alpha7-nicotinic acetylcholine receptor. Ann Surg 2009; 249: 978-985.
42. Tanaka N, Odajima T, Ogi K, Ikeda T, Satoh M,. Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer 2003; 89: 557-563. (Pubitemid 37026443)
43. Pyo SW, Hashimoto M, Kim YS, et al. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg 2007; 35: 1-9.